ImmunoGen (IMGN) ROE US GAAP (year values) |
||||||||
2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | |||
ROE, % | ? | -1 406% | 160.4% | -74.4% | -143.1% | -143.1% | 9.44% | |
Changes by years, y/y, % | -1 942pp | +1 566pp | -235pp | -69pp | 0pp |
ImmunoGen. ROE, %
ImmunoGen. ROE, changes, pp
ImmunoGen (IMGN) ROE US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q4 | 2023Q2 | 2023Q3 | 2024Q1 | LTM ? | |||
ROE, % | ? | -120.5% | -3.73% | -3.73% | 9.44% | 9.44% | 9.44% | |
Changes by years, y/y, % | -75pp | +141pp | +77pp | +125pp | +130pp | |||
Changes by quarters, q/q, % | -94pp | +117pp | 0pp | +13pp | 0pp |